Mizuho Securities USA’s AbbVie ABBV Stock Holding History

Mizuho Securities USA’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.8M	Buy	138,320 +31,474	+29%	+$6.77M	0.56%	24
2026 Q1	$23.2M	Sell	106,846 -21,843	-17%	-$4.85M	0.55%	24
2025 Q4	$29.3M	Buy	128,689 +25	+0%	+$5.7K	0.48%	24
2025 Q3	$27.1M	Buy	128,664 +6,589	+5%	+$1.34M	0.55%	25
2025 Q2	$22.7M	Sell	122,075 -19,277	-14%	-$3.58M	0.48%	29
2025 Q1	$29.6M	Sell	141,352 -26,133	-16%	-$5.08M	0.64%	25
2024 Q4	$29.8M	Buy	167,485 +52,947	+46%	+$9.73M	0.54%	25
2024 Q3	$22.6M	Sell	114,538 -21,611	-16%	-$4.03M	0.49%	24
2024 Q2	$23.4M	Buy	+136,149	New	+$22.6M	0.52%	28
2020 Q3	–	Sell	-3,690	Closed	-$362K	–	164
2020 Q2	$362K	Buy	+3,690	New	+$325K	0.02%	116

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mizuho Securities USA's ABBV Position: Q2 2026 in Review

Mizuho Securities USA increased its AbbVie (ABBV) stake by 29% in Q2 2026, buying an estimated $6.77M and bringing the position to 138,320 shares worth $34.8M. The position accounts for 0.56% of the portfolio, ranked #24.

Mizuho Securities USA first reported a position in ABBV in Q2 2020 and has held it in 10 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Mizuho Securities USA held 138,320 shares of AbbVie worth $34.8M as of Q2 2026.
Mizuho Securities USA bought 31,474 AbbVie shares in Q2 2026, an estimated $6.77M.
AbbVie made up 0.56% of Mizuho Securities USA's portfolio in Q2 2026, its #24 holding.
Mizuho Securities USA first reported a position in AbbVie in Q2 2020 and has held it in 10 quarters since.
4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.